Search results
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon - ...
Benzinga· 2 hours agoOn Monday, Moderna MRNA and Merck & Co MRK also reported durable efficiency of their combined...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 2 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 4 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 7 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...
US approves Moderna’s RSV vaccine for older adults | FOX 28 Spokane
FOX 28 Spokane· 4 days agovaccine for older adults — marking the first time any mRNA shot has been authorized against a...
COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events
MedPage Today· 5 days agoCardiopulmonary events included all-cause death, myocardial infarction (MI), stroke, urgent coronary...
Fauci’s testimony reverberates in Florida
Politico· 9 hours agoBut Fauci didn’t budge on the importance of vaccines and predicted 1 million more people would have died if the virus had been allowed to...comments come roughly six weeks ...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoProtection against infection 4 weeks after vaccination was 52%, and against COVID-related hospital...
